• Uptravi® (SelexiPag): tHe usErs dRug rEgistry (SPHERE) Registry Uptravi® (Selexipag) Users Registry PROTOCOL: AC-065A402
• A randomised, double-blind, placebo-controlled, parallel group, dose-finding study evaluating efficacy, safety and tolerability of BI 1291583 qd over at least 24 weeks in patients with bronchiectasis. (20222253)
• A Phase 2a Multiple Ascending Dose Study to Examine the Safety, Tolerability and Efficacy of AV-001 Injection in Patients with Pneumonia Due To COVID-19 or Respiratory Infections. OPEN ENROLLMENT
• An Open-label Extension Study of Inhaled Treprostinil in Subjects with Fibrotic Lung Disease (20212063) OPEN ENROLLMENT
• A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis (20210052) OPEN ENROLLMENT
• Study of Benralizumab in Patients with Chronic Obstructive Pulmonary Disease with a History of Frequent COPD Exacerbations and Elevated Peripheral Blood Eosinophils OPEN ENROLLMENT
• A study to Assess the Efficacy, Safety, and Pharmacokinetics of Orally Administered Epetraborole in Patients with Treatment-refractory Mycobacterium avium Complex Lung Disease OPEN ENROLLMENT
• A randomised, double-blind, placebo-controlled, parallel group, dose-finding study evaluating efficacy, safety and tolerability of BI 1291583 qd over at least 24 weeks in patients with bronchiectasis (Airleaf™)
• A Study to Evaluate an Amikacin Liposome Inhalation Suspension Based Regimen in Adults with Newly Diagnosed NTM Lung Infection Caused by Mycobacterium avium Complex (MAC) OPEN ENROLLMENT
• A 52-week study assessing exacerbation rate, asthma control and safety in adult severe eosinophilic asthmatics treated with depemokimab compared with mepolizumab or benralizumab OPEN ENROLLMENT